Cubist Systematic Strategies, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 131 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$16,000
-84.0%
13,691
-69.2%
0.00%
-100.0%
Q4 2021$100,000
-63.1%
44,434
-50.9%
0.00%
-66.7%
Q2 2021$271,000
-63.2%
90,500
-60.4%
0.00%
-66.7%
Q1 2021$737,000
+2848.0%
228,250
+1615.5%
0.01%
+800.0%
Q1 2019$25,000
-82.3%
13,305
-50.3%
0.00%
-87.5%
Q1 2016$141,000
-28.8%
26,772
+6.4%
0.01%
-33.3%
Q4 2015$198,000
-25.6%
25,173
-20.1%
0.01%
-7.7%
Q3 2015$266,000
+58.3%
31,501
+105.5%
0.01%
+62.5%
Q2 2015$168,000
-85.2%
15,330
-81.2%
0.01%
-85.7%
Q1 2015$1,137,000
+28.3%
81,350
+55.0%
0.06%
+16.7%
Q4 2014$886,000
+2171.8%
52,476
+1709.5%
0.05%
+2300.0%
Q3 2014$39,0002,9000.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$7,561,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$1,756,0000.24%
EAM Investors, LLC 840,556$1,000,0000.22%
Gratus Capital, LLC 1,249,248$1,487,0000.16%
Ally Bridge Group (NY) LLC 86,242$103,0000.07%
MARINER INDEPENDENT ADVISOR NETWORK, LLC 1,252,822$1,491,0000.06%
Bleichroeder LP 250,000$298,0000.06%
GSA CAPITAL PARTNERS LLP 324,784$386,0000.05%
Polar Capital Holdings Plc 5,000,000$5,950,0000.04%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$649,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders